ArticleBMC veterinary research2025
Potential impact of L-threonine and encapsulated butyric acid (ButiPEARL) on growth performance, serum biomarkers, intestinal histomorphometry and economic indices of Nile tilapia fingerlings.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nutritional detoxification strategies in aquaculture: bioactive feed additives mitigating oxidative stress and xenobiotic toxicity in fish.Fish physiology and biochemistry · 2026Review
- Age-Related Involutory Changes in Bursa of Fabricius of Anas crecca: Histomorphometric and Ultrastructural Investigation.Veterinary medicine and science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNumerous immunostimulants have been incorporated as additives in aquaculture feed due to their potential to improve growth and improve immune function. The present study investigated the effects of dietary L-threonine and an encapsulated butyric acid (ButiPEARL) on several parameters related to Nile tilapia, Oreochromis niloticus, specifically focusing on growth performance and immune response. MATERIALS AND
methodsA total of 486 Nile tilapia fingerlings were divided into six experimental fish groups (n = 81). Each replicate consisted of 27 fish that were used, weighing approximately 15 ± 0.5 (g) and measuring 7 ± 0.5 (cm). The fish in the control group (G1) were fed a basal diet, while the fish in the other groups were fed experimental diets that included varying concentrations of butyric acid and L-threonine per kilogram of diet, as the second group (G2) fed on a basal diet supplemented with butyric acid 0.3 g/kg diet, the third group (G3) fed on a basal diet supplemented with L-threonine 0.24 g/kg diet, the fourth group (G4) fed on a basal diet supplemented with butyric 0.3 g/kg + L-threonine 0.24 g/kg diet, the fifth group (G5) fed on a basal diet supplemented with L-threonine 0.48 g/kg diet, and the sixth group (G6) fed on a basal diet supplemented with butyric 0.3 g/kg + L-threonine 0.48 g/kg. The feeding was done twice a day for 42 days, with the amount of food given being 5% of the fish's body weight. The water parameters were maintained at suitable levels.
resultsThe supplementation of these feed additives, particularly the group of fish fed a diet containing 0.3 g/kg of encapsulated butyric acid (ButiPEARL) mixed with 0.48 g/kg of L-threonine, exhibited the highest values throughout the experiment. This supplementation significantly enhanced growth performance indicators (P < 0.05), such as length gain, weight gain, weight gain rate (WGR), specific growth rate (SGR), and feed conversion ratio (FCR). Furthermore, it positively influenced immunological parameters (IgM, albumin, total protein in serum, and nitrous oxide in liver tissue), liver enzymes (ALT, AST in serum), antioxidants (superoxide dismutase and catalase) and malondialdehyde in liver), biochemical assays (plasma glucose concentrations), and digestive enzymes (lipase and amylase) in plasma (P < 0.05). In terms of fish farm profitability, a higher net profit can be achieved by maximizing returns while minimizing costs. The histology and scanning electron microscopy (SEM) analysis of the O. niloticus intestines revealed significant improvements in the length and width of intestinal villi (P < 0.05). DISCUSSION AND
conclusionThe inclusion of L-threonine (0.48g/kg) and encapsulated butyric acid (ButiPEARL) (0.3g/kg) in fish diets can serve as safe, natural, and cost-effective feed additives. It is recommended to use a combined inclusion level of these additives to enhance growth, boost immunity, support liver function, and promote intestinal development. Future research to evaluate the advantages of a dietary combination of encapsulated butyric acid and L-threonine at varying doses in aquaculture is encouraged by the findings of this investigation. However, additional research is required to ascertain these compounds' potential impact on other fish species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.